Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Singer

Showing results (431-440 of 771) with videos related to

Pageof 78
Sort By:
American Journal of Public Health|August 1, 1988
Sociodemographic and behavioral characteristics of HIV antibody-positive blood donorsP D Cleary, E Singer, T F Rogers, et al.
Preventive Medicine|August 12, 2000
Smoking by patients in a smoke-free hospital: prevalence, predictors, and implicationsN A Rigotti, J H Arnsten, K M McKool, et al.
Journal of the American College of Cardiology|July 16, 2011
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) StudyMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
Journal of the American Geriatrics Society|November 19, 2016
Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation StudyJeffrey M Ashburner, Alan S Go, Yuchiao Chang, et al.
Annals of Internal Medicine|November 17, 2004
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillationMargaret C Fang, Yuchiao Chang, Elaine M Hylek, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA studyDaniel E Singer, Yuchiao Chang, Margaret C Fang, et al.
JAMA Neurology|August 15, 2018
Association of Intracranial Hemorrhage Risk With Non-Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysisWen-Yi Huang, Daniel E Singer, Yi-Ling Wu, et al.
Journal of the American College of Cardiology|May 14, 2016
Reply: Comparing the ATRIA, CHADS2, and CHA2DS2-VASc Scores for Stroke Prediction in Atrial FibrillationHendrika A van den Ham, Olaf H Klungel, Daniel E Singer, et al.
Bioethics|October 22, 2016
Ethical, Legal, and Social Implications of Personalized Genomic Medicine Research: Current Literature and Suggestions for the FutureShawneequa L Callier, Rachel Abudu, Maxwell J Mehlman, et al.
Circulation. Cardiovascular Quality and Outcomes|October 21, 2010
Warfarin discontinuation after starting warfarin for atrial fibrillationMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
Pageof 78

Showing results (431-440 of 771) with videos related to

Sort By:
Pageof 78
American Journal of Public Health|August 1, 1988
Sociodemographic and behavioral characteristics of HIV antibody-positive blood donorsP D Cleary, E Singer, T F Rogers, et al.
Preventive Medicine|August 12, 2000
Smoking by patients in a smoke-free hospital: prevalence, predictors, and implicationsN A Rigotti, J H Arnsten, K M McKool, et al.
Journal of the American College of Cardiology|July 16, 2011
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) StudyMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
Journal of the American Geriatrics Society|November 19, 2016
Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation StudyJeffrey M Ashburner, Alan S Go, Yuchiao Chang, et al.
Annals of Internal Medicine|November 17, 2004
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillationMargaret C Fang, Yuchiao Chang, Elaine M Hylek, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA studyDaniel E Singer, Yuchiao Chang, Margaret C Fang, et al.
JAMA Neurology|August 15, 2018
Association of Intracranial Hemorrhage Risk With Non-Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysisWen-Yi Huang, Daniel E Singer, Yi-Ling Wu, et al.
Journal of the American College of Cardiology|May 14, 2016
Reply: Comparing the ATRIA, CHADS2, and CHA2DS2-VASc Scores for Stroke Prediction in Atrial FibrillationHendrika A van den Ham, Olaf H Klungel, Daniel E Singer, et al.
Bioethics|October 22, 2016
Ethical, Legal, and Social Implications of Personalized Genomic Medicine Research: Current Literature and Suggestions for the FutureShawneequa L Callier, Rachel Abudu, Maxwell J Mehlman, et al.
Circulation. Cardiovascular Quality and Outcomes|October 21, 2010
Warfarin discontinuation after starting warfarin for atrial fibrillationMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
Pageof 78